CIR Director Gill Steps Down, Leaving Legacy Of Improved Transparency
This article was originally published in The Rose Sheet
Lillian Gill, director of the Cosmetic Ingredient Review, helped to bolster CIR’s international reputation during her four-year stint leading the group. CIR’s profile has risen as a result of her leadership, openness to outside stakeholder input and increased public interest in cosmetic ingredients’ safety overall.
You may also be interested in...
The Cosmetic Ingredient Review Expert Panel will take another look at paraben safety during its June meeting, considering new studies and adding ingredients to its assessment on the preservative group. NGO Women’s Voices for the Earth suggests that the panel may still be missing several relevant studies.
Going into the Cosmetic Ingredient Review Expert Panel’s review of boilerplate language for aerosols, Women’s Voices for the Earth raised concerns about aerosol particle sizes and the potential for respiratory harm from inhalation. Panel members agreed that the NGO presented some valid points and said they plan to look into updates.
The Personal Care Products Council has a vision for marrying the Cosmetic Ingredient Review’s expertise with FDA’s authority, which it hopes to package into reform legislation expected this year. While FDA has balked at formalizing CIR’s role under previous proposals, this one was inspired by a third-party review program for medical devices, making it potentially more palatable to the agency and lawmakers.